Transcode Therapeutics Inc (RNAZ) Key Ratios

Stock Card

$2.18

$-0.10 (-4.39%)

As on 28-Aug-2026 16:24EDT

Market cap

$2 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

2.8

Div. Yield

0 %

Key Ratios and Highlights

Growth Score (%)	Quarterly		Annual (TTM)
Particulars	QoQ	YoY	1-Year	3-Years	5-Years
Revenue	--	--	--	--	--
EBIT	61.41	-58.39	-55.02	-24.53	-242.44
Net Profit	62.33	-56.67	-103.39	-167.12	-255.18
EPS	63.14	-39.37	46.80	23.88	14.74
Book Value	--	--	--	-52.66	--

Key Ratios (%)	Average		Annual (TTM)
Particulars	3-Years	5-Years	TTM	Dec-25	Dec-24
EBIT-Margin	--	--	--	--	--
Net Margin	--	--	--	--	--
Return on equity	2,424.53	1,408.90	-29.48	-833.53	8,866.96
Return on Capital	-10,576.67	-6,390.06	--	-829.71	-30,204.65
Return on Assets	-200.15	-154.51	-49.90	-40.85	-268.85
Debt to Equity (x)	--	--	0.00	--	-0.02

Profitability

View Detailed Peer Comparison

ROCE

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	--	-829.71	-30,204.65	-695.64	-148.57
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROE

-29.48

Higher than Peers by 10.92

Profit after tax / Average Net worth * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	-29.48	-833.53	8,866.96	-759.85	-148.57
Peer Median	-40.40	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROA

-49.90

Lower than Peers by 18.92

Profit after tax / Average Total assets * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	-49.90	-40.85	-268.85	-290.74	-115.08
Peer Median	-30.98	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

EBIT Growth

-55.02

Lower than Peers by 54.23

Year on year growth in operating profit (EBIT)

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	-55.02	-105.81	9.53	-5.27	-160.29
Peer Median	-0.80	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Net Profit Growth

-103.39

Lower than Peers by 96.09

Year on year growth in profit after tax

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	-103.39	-106.87	9.66	-5.59	-156.67
Peer Median	-7.30	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EPS Growth

46.80

Higher than Peers by 32.15

Year on year growth in earnings per share

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	46.80	0.20	0.95	-0.69	-0.36
Peer Median	14.65	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Book Value Growth

1,902.02

Higher than Peers by 1,912.20

Year on year growth in book value per share

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	1,902.02	--	--	--	--
Peer Median	-10.18	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

Total debt / Net worth

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	--	--	-0.02	0.27	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Short term debt to equity ratio

0.00

(Short term borrowings / Net worth)

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	0.00	--	-0.02	0.25	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Current Ratio

1.97

Lower than Peers by 3.84

Current Assets / Current Liabilities and Provisions

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	1.97	6.29	2.56	1.28	1.70
Peer Median	5.81	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Quick Ratio

1.97

Lower than Peers by 3.72

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	1.97	--	--	--	1.57
Peer Median	5.70	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Interest Coverage

-6,015.00

Lower than Peers by 6,012.91

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	-6,015.00	-5,203.81	-623.88	-330.78	-1.00
Peer Median	-2.09	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Asset Turnover

Sales / Average Total Assets

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	--	--	--	--	--
Peer Median	0.06	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Inventory Days

Average Inventory / Sales * 365

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	--	--	--	391.82	2,053.31
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Payable days

Average Creditors / Cost of goods sold * 365

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	--	9,109.85	1,675.81	2,281.88	11,373.81
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

Current share price divided by earning per share in the last twelve months

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	--	-0.18	-0.07	0.00	0.00
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Price / Book Value

2.83

Lower than Peers by 2.36

Current share price divided by book value per share in the latest financial year

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	2.83	0.61	-0.59	0.00	0.01
Peer Median	5.18	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Dividend Yield

Dividend per share in the past twelve months divided by current share price

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	--	--	--	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EV/EBITDA

-0.59

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	-0.59	0.34	0.28	0.13	0.28
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Market Cap

Lower than Peers by 144

Current Share price multiplied by latest total number of shares outstanding

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22
Transcode Therapeutics Inc (RNAZ)	2	--	--	--	--
Peer Median	146	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly